Lvw Advisors, LLC Astrazeneca PLC Transaction History

Lvw Advisors, LLC

$804 Million
Q4 2024

A detailed history of Lvw Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Lvw Advisors, LLC holds 15,962 shares of AZN stock, worth $1.19 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

15,962

Previous 17,526 8.92%

Holding current value

$1.19 Million

Previous $1.37 Million 23.44%

% of portfolio

0.13%

Previous 0.18%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 16, 2025	SELL	$63.2 - $79.58 $98,844 - $124,463	-1,564 Reduced 8.92%	15,962 $1.05 Million
Q3 2024 Oct 09, 2024	SELL	$76.67 - $87.62 $118,685 - $135,635	-1,548 Reduced 8.12%	17,526 $1.37 Million
Q2 2024 Jul 15, 2024	BUY	$66.81 - $80.83 $28,327 - $34,271	424 Added 2.27%	19,074 $1.49 Million
Q1 2024 Apr 17, 2024	BUY	$61.03 - $69.57 $92,582 - $105,537	1,517 Added 8.85%	18,650 $1.26 Million
Q4 2023 Jan 12, 2024	SELL	$61.89 - $69.28 $123 - $138	-2 Reduced 0.01%	17,133 $1.15 Million
Q3 2023 Oct 10, 2023	SELL	$64.85 - $71.7 $105,251 - $116,369	-1,623 Reduced 8.65%	17,135 $1.16 Million
Q2 2023 Jul 14, 2023	SELL	$69.91 - $75.81 $208,191 - $225,762	-2,978 Reduced 13.7%	18,758 $1.34 Million
Q1 2023 May 02, 2023	SELL	$63.15 - $71.6 $31,827 - $36,086	-504 Reduced 2.27%	21,736 $1.51 Million
Q4 2022 Jan 18, 2023	BUY	$54.21 - $70.44 $67,057 - $87,134	1,237 Added 5.89%	22,240 $0
Q3 2022 Oct 13, 2022	SELL	$53.02 - $135.75 $6,998 - $17,919	-132 Reduced 0.62%	21,003 $1.15 Million
Q2 2022 Jul 22, 2022	SELL	$59.26 - $71.14 $46,163 - $55,418	-779 Reduced 3.55%	21,135 $1.4 Million
Q1 2022 May 02, 2022	SELL	$55.72 - $67.12 $88,149 - $106,183	-1,582 Reduced 6.73%	21,914 $1.45 Million
Q4 2021 Jan 26, 2022	SELL	$54.02 - $63.83 $103,232 - $121,979	-1,911 Reduced 7.52%	23,496 $1.37 Million
Q3 2021 Nov 02, 2021	BUY	$55.56 - $60.79 $4,111 - $4,498	74 Added 0.29%	25,407 $1.53 Million
Q2 2021 Jul 15, 2021	BUY	$48.42 - $60.18 $5,374 - $6,679	111 Added 0.44%	25,333 $1.52 Million
Q1 2021 Apr 19, 2021	BUY	$47.16 - $54.44 $296,730 - $342,536	6,292 Added 33.24%	25,222 $1.25 Million
Q4 2020 Feb 04, 2021	SELL	$48.52 - $58.02 $45,851 - $54,828	-945 Reduced 4.75%	18,930 $946,000
Q3 2020 Oct 29, 2020	SELL	$53.07 - $61.1 $269,807 - $310,632	-5,084 Reduced 20.37%	19,875 $1.09 Million
Q2 2020 Aug 11, 2020	BUY	$43.1 - $55.31 $102,793 - $131,914	2,385 Added 10.57%	24,959 $1.32 Million
Q1 2020 Apr 23, 2020	BUY	$37.79 - $51.33 $358,249 - $486,608	9,480 Added 72.4%	22,574 $1.01 Million
Q4 2019 Feb 10, 2020	SELL	$42.46 - $50.46 $154,809 - $183,977	-3,646 Reduced 21.78%	13,094 $653,000
Q3 2019 Oct 22, 2019	BUY	$40.12 - $45.47 $334,520 - $379,128	8,338 Added 99.24%	16,740 $746,000
Q2 2019 Aug 14, 2019	BUY	$37.28 - $41.68 $100,469 - $112,327	2,695 Added 47.22%	8,402 $347,000
Q1 2019 May 03, 2019	BUY	$35.49 - $43.02 $202,541 - $245,515	5,707 New	5,707 $231,000

Others Institutions Holding AZN

# of Institutions

1,357

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $231B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account